Literature DB >> 6434359

Radial arm maze performance in rats following neonatal dopamine depletion.

D E Pearson, L A Raskin, B A Shaywitz, G M Anderson, D J Cohen.   

Abstract

Neonatal dopamine (DA) depletion produces learning impairments both during development and throughout adulthood in the rat. The present experiment further investigated the memory capabilities of the dopamine-depleted rat by assessing performance in the radial arm maze. Results showed that, following neonatal injection of 6-hydroxydopamine and desmethylimipramine, lesioned rats per-performed more accurately than controls. In this paradigm, DA-depleted rats tended to enter each arm to obtain a food pellet and not enter unbaited, incorrect arms. The difference in performance of control and treated rats could not be accounted for by differences in locomotor activity, body weights, or motivational factors. A computer analysis of the data revealed that DA-depleted animals adopted a strategy of choosing adjacent arms consecutively, which probably accounted for their superior performance. Results are discussed in terms using algorithms versus extra-maze cues to complete the maze following early brain injury.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434359     DOI: 10.1002/dev.420170508

Source DB:  PubMed          Journal:  Dev Psychobiol        ISSN: 0012-1630            Impact factor:   3.038


  2 in total

1.  Altered Corticostriatal Connectivity and Exploration/Exploitation Imbalance Emerge as Intermediate Phenotypes for a Neonatal Dopamine Dysfunction.

Authors:  Barbara Y Braz; Gregorio L Galiñanes; Irene R E Taravini; Juan E Belforte; M Gustavo Murer
Journal:  Neuropsychopharmacology       Date:  2015-04-15       Impact factor: 7.853

2.  Altered operant responding for motor reinforcement and the determination of benchmark doses following perinatal exposure to low-level 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  V P Markowski; G Zareba; S Stern; C Cox; B Weiss
Journal:  Environ Health Perspect       Date:  2001-06       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.